• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Align Technology Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/21/25 5:04:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    algn-20250521
    0001097149false00010971492025-05-212025-05-21


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 21, 2025

    ALIGN TECHNOLOGY, INC.
    (Exact name of registrant as specified in its charter)
    Delaware000-3225994-3267295
    (State or other jurisdiction of incorporation)
    (Commission File Number)
    (IRS Employer Identification No.)

    410 North Scottsdale Road, Suite 1300 Tempe, Arizona 85288
    (Address of principal executive offices) (Zip Code)
    (602) 742-2000
    (Registrant’s telephone number, including area code)

    Not applicable
    (Former name or former address, if changed since last report.)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of exchange on which registered
    Common stock, $0.0001 par valueALGNThe NASDAQ Stock Market LLC
     (NASDAQ Global Select Market)

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17  CFR §240.12b-2). 
    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On May 21, 2025, Align Technology, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment to the Align Technology, Inc. 2005 Incentive Plan (as amended to date, the “Incentive Plan”). A summary of the Incentive Plan’s principal provisions is set forth in the Company’s 2025 Proxy Statement, dated April 8, 2025 (the “Proxy Statement”), in the section entitled “Company Proposal 5: Approval of an Amendment to the Align Technology, Inc. 2005 Incentive Plan,” which summary is incorporated herein by reference.

    The description of the Incentive Plan is qualified in its entirety by reference to the Incentive Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.


    Item 5.07    Submission of Matters to a Vote of Security Holders.

    On May 21, 2025, the Company held the Annual Meeting. The voting results for each item of business presented at the Annual Meeting, as certified by the Company’s inspector of elections, are set forth below:

    Proposal 1: Election of the ten director nominees named below at the Annual Meeting, each to serve for a one-year term or until a successor is duly elected or appointed and qualified.

    Name
    ForAgainstAbstain
    Broker Non-Votes
    C. Raymond Larkin, Jr.
    54,474,8654,586,871117,3474,054,395
    Kevin T. Conroy
    58,380,774682,189116,1204,054,395
    Kevin J. Dallas58,368,991694,010116,0834,054,395
    Joseph M. Hogan58,287,184773,858118,0414,054,395
    Joseph Lacob50,773,1928,289,939115,9524,054,395
    George J. Morrow52,093,0316,970,070115,9804,054,395
    Anne M. Myong57,637,3771,425,893115,8124,054,395
    Mojdeh Poul
    55,729,9333,003,047446,1034,054,395
    Andrea L. Saia56,803,5562,259,347116,1784,054,395
    Susan E. Siegel57,869,3411,194,265115,4774,054,395


    Proposal 2: An advisory (non-binding) vote to approve the compensation of the Company’s named executive officers.

    ForAgainstAbstain
    Broker Non-Votes
    51,634,3147,428,786115,9754,054,395


    Proposal 3: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.

    ForAgainstAbstain
    57,008,9206,117,545107,001

    Proposal 4: Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to replace each supermajority provision with a simple majority vote requirement.




    ForAgainstAbstain
    Broker Non-Votes
    58,954,113154,48270,4874,054,395

    Proposal 5: Approval of an amendment to the Align Technology, Inc. 2005 Incentive Plan to increase the number of shares authorized for issuance thereunder.

    ForAgainstAbstain
    Broker Non-Votes
    56,414,8462,513,458250,7764,054,395

    Proposal 6: Advisory vote to allow stockholders owning 25% of the Company’s outstanding common stock to call a special meeting of stockholders.

    ForAgainstAbstain
    Broker Non-Votes
    38,706,29314,717,6395,755,1424,054,395

    Proposal 7: Support for shareholder ability to call for a special shareholder meeting.

    ForAgainstAbstain
    Broker Non-Votes
    26,687,16432,371,257120,6504,054,395

    Item 9.01    Financial Statements and Exhibits.

    (d) Exhibits

    Exhibit No.Description
    10.1
    Align Technology, Inc. 2005 Incentive Plan (as amended on May 21, 2025)
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)





    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ALIGN TECHNOLOGY, INC.
    By:/s/ Julie Coletti
    Julie Coletti
    Executive Vice President, Chief Legal and Regulatory Officer

    Date: May 21, 2025





    Get the next $ALGN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    12/11/2023$197.00Neutral → Sell
    Goldman
    10/27/2023$200.00Buy → Neutral
    UBS
    More analyst ratings

    $ALGN
    SEC Filings

    See more
    • Align Technology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      7/2/25 4:32:25 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SD filed by Align Technology Inc.

      SD - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/30/25 5:03:05 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/21/25 5:04:42 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Britt Vitalone Joins Align Technology Board of Directors

      Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Britt Vitalone, Executive Vice President and Chief Financial Officer ("CFO"), McKesson Corporation, to Align's Board of Directors along with its Audit Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702733967/en/Britt Vitalone (photo) "I am pleased to welcome Britt to Align's board of dire

      7/2/25 4:35:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Announce Second Quarter 2025 Results on July 30, 2025

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

      7/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Connects With Over 2,000 Doctors and Practice Staff at the 2025 Invisalign® Asia Pacific (APAC) Summit

      Align reinforces commitment to innovation, community and partnership with the dental profession across the Asia Pacific region Showcases latest innovations across iTero digital scanning, treatment planning and treating growing children and teens Celebrates 20 million Invisalign Smiles milestone globally and 3 million Invisalign Smiles across Asia Pacific with "20M smiles, 20M stories, endless possibilities" Adjacent Align APAC University Forum underscores importance of education, learning and partnership Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ i

      6/27/25 5:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Align Tech downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

      4/25/25 8:29:20 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Wells Fargo initiated coverage on Align Tech with a new price target

      Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00

      2/14/25 7:02:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Tech upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously

      1/6/25 7:28:53 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Conroy Kevin T converted options into 1,148 shares, increasing direct ownership by 174% to 1,808 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      5/22/25 5:49:46 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Director Siegel Susan E converted options into 1,148 shares, increasing direct ownership by 15% to 8,978 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      5/22/25 5:14:17 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Director Saia Andrea Lynn converted options into 1,148 shares, increasing direct ownership by 8% to 15,573 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      5/22/25 5:13:34 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      8/19/24 6:35:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,845 worth of shares (5,194 units at $192.50), increasing direct ownership by 3% to 208,664 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/9/23 8:35:10 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,972 worth of shares (5,319 units at $188.00), increasing direct ownership by 3% to 203,470 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/1/23 5:18:50 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/13/24 4:59:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/24 4:31:42 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/23 11:07:31 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    See more
    • Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

      Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

      3/25/25 4:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

      5/22/24 5:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

      2/8/23 4:55:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Financials

    Live finance-specific insights

    See more
    • Align Technology to Announce Second Quarter 2025 Results on July 30, 2025

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

      7/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Announce First Quarter 2025 Results on April 30, 2025

      Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

      4/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care